Daiwa Securities Group Inc. Cytokinetics Inc Transaction History
Daiwa Securities Group Inc.
- $27.1 Billion
- Q2 2025
A detailed history of Daiwa Securities Group Inc. transactions in Cytokinetics Inc stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 429 shares of CYTK stock, worth $25,757. This represents 0.0% of its overall portfolio holdings.
Number of Shares
429
Previous 389
10.28%
Holding current value
$25,757
Previous $16,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CYTK
# of Institutions
371Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.06 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$881 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$720 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$470 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$383 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.65B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...